elfman - the 26,000 doses may have been run off as part of the process qualification/ process robustness work? Or purely for the purpose of providing material to stability test. Always better to start that early.
But very much agree with the importance of your point that it must be cheap to make
elfman - 3 Jan'06 - 18:25 - 27053 of 27063
Might explain why OXB have been stock-piling the vaccine, which was about 26,000 from memory. Were they (the company) trying to tell us something by stating the number in storage. At the very least it tells us the vaccine is cheap to make and that it has a reasonable shelf-life
Oxford Biomed stock quotes
Oxford Biomed stock charts
Follow this thread
